
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
王靓, 侯晓燕, 黄金玲, 等. 苓桂术甘汤对急性心肌梗死后心室重构模型大鼠NF-B的影响[J]. 中国实验方剂学杂志, 2012,18(20):176-179.
WANG Liang, HOU Xiao-yan, HUANG Jin-ling, et al. Effects of Linggui Zhugan Decoction on NF-B in Rats with Ventricular Remodeling after Acute Myocardial Infarction[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(20): 176-179.
王靓, 侯晓燕, 黄金玲, 等. 苓桂术甘汤对急性心肌梗死后心室重构模型大鼠NF-B的影响[J]. 中国实验方剂学杂志, 2012,18(20):176-179. DOI:
WANG Liang, HOU Xiao-yan, HUANG Jin-ling, et al. Effects of Linggui Zhugan Decoction on NF-B in Rats with Ventricular Remodeling after Acute Myocardial Infarction[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(20): 176-179. DOI:
目的: 观察苓桂术甘汤对急性心肌梗死(acute myocardial infarction
AMI)后心室重构模型大鼠心肌组织核因子-κB(nuclear factor-κB
NF-κB)及NF-κB mRNA表达
血清NF-κB含量的影响
探讨苓桂术甘汤干预AMI后心室重构(ventricular remodeling
VR)的作用机制。 方法: 采用冠状动脉结扎法复制心室重构大鼠模型
造模2周后将模型大鼠随机分为模型组
卡托普利4.4 mg·kg-1组
苓桂术甘汤(按生药量计)低、中、高剂量(2.1
4.2
8.4 g·kg-1)组
另设假手术组
分别ig给药
连续给药4周
采用Western blot
RT-PCR及ELISA技术检测各组大鼠心肌组织NF-κB
NF-κB mRNA表达
血清NF-κB含量。 结果: 假手术组
模型组
苓桂术甘汤低、中、高剂量组
卡托普利组的心肌组织NF-κB相对表达量(NF-κB/β-actin)分别为:0.190±0.011
0.772±0.026
0.366±0.059
0.295±0.033
0.235±0.013
0.341±0.023;NF-κB mRNA相对表达量分别为:1.000
26.875
6.574
4.340
1.194
5.540;血清NF-κB含量分别为(125.85±14.76)
(196.98±17.79)
(163.89±20.08)
(131.73±10.47)
(141.93±10.32)
(133.93±9.27)ng·L-1。模型组与假手术组比心肌组织NF-κB
NF-κB mRNA表达、血清NF-κB含量均显著升高(P<0.01);苓桂术甘汤各剂量组及卡托普利组能够显著抑制模型大鼠心肌组织NF-κB
NF-κB mRNA表达、降低模型大鼠血清NF-κB含量
与模型组比有显著性差异(P<0.01或P<0.05)。 结论: 苓桂术甘汤干预AMI后VR的机制与其抑制NF-κB有关。
Objective:To study the mechanism of Linggui Zhugan decoction (LGZGD)interference on ventricular remodeling (VR) in rats after acute myocardial infarction (AMI)
through observing the expression of nuclear factor-κB(NF-κB)and NF-κB mRNA of myocardial tissue and the content of NF-κB in ventricular remodeling rats with AMI. Method: AMI model was produced by ligation of coronary artery. 2 weeks after modeling
rats were randomly classified into model
captopril
and low (2.1 g·kg-1)
middle(4.2 g·kg-1) and high (8.4 g·kg-1)dosage of LGZGD group. Control group and the other 5 groups were administered medications intragastrically for 4 consecutive weeks. The content of NF-κB in myocardial tissue and serum was detected by ELISA and the expression of NF-κB was assayed by RT-PCR and the expression of NF-κB mRNA by Western blot. Result: For sham-operation
model
low
middle and large dosage of LGZGD group and captopril group
the content of NF-κB of myocardial tissue was 0.190±0.011
0.772±0.026
0.366±0.059
0.295±0.033
0.235±0.013
0.341±0.023.The relative expression of NF-κB mRNA were 1.000
26.875
6.574
4.340
1.194
5.540.The content of serum NF-κB were (125.85±14.76)
(196.98±17.79)
(163.89±20.08)
(131.73±10.47)
(141.93±10.33)
(133.93±9.27)ng·L-1.The content of NF-κB in serum and the expression of NF-κB
NF-κB mRNA of myocardial tissue of model group increased significantly compared with control group (P<0.01). Low
middle and high dosage of LGZGD and captopril group could decrease the content of NF-κB in serum and inhibited the expression of NF-κB
NF-κB mRNA in myocardial tissue of model rats significantly compared with model group (P<0.01 or P<0.05). Conclusion: The mechanism of LGZGD interference VR of post-AMI seems to be related to the inhibition of NF-κB.
0
浏览量
5
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621